Epigenomic biomarkers of cardiometabolic disease: How far are we from daily practice?

Abstract excerpt

Determining whether someone has cardiometabolic disease (CMD), especially in the early stages, can be complicated. Risk stratification ordinarily depends on an extended process relying on medical history that typically considers blood pressure, cholesterol, smoking and diabetes status. Physicians have long relied on these key patient characteristics to assess CMD risk. However, these widely used clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomarkers
• Share to Cardiometabolic Risk Factors
• Share to Cardiovascular Diseases